The global cervical dysplasia treatment market is on a trajectory of steady expansion, with projections indicating a rise from USD 628.5 million in 2023 to USD 846.2 million by 2033. This growth, at a ...

The U.S. Food and Drug Administration on Friday approved Teal Health to provide the nation's first at-home test kit to screen for cervical cancer.

The FDA has approved the first and only self-collection cervical cancer screening device, where patients can obtain their own samples from the comfort of their own home. The Teal Wand, manufactured by ...